首页> 美国卫生研究院文献>Cancer Science >Allelic Loss at the Tuberous Sclerosis (Tsc2) Gene Locus in Spontaneous Uterine Leiomyosarcomas and Pituitary Adenomas in the Eker Rat Model
【2h】

Allelic Loss at the Tuberous Sclerosis (Tsc2) Gene Locus in Spontaneous Uterine Leiomyosarcomas and Pituitary Adenomas in the Eker Rat Model

机译:Eker大鼠模型中自发性子宫平滑肌肉瘤和垂体腺瘤的结节性硬化症(Tsc2)基因位点的等位基因缺失

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hereditary renal carcinomas (RCs) develop in virtually all Eker rats by the age of one year. Investigation of extra‐renal primary tumors co‐occurring in Eker rats late in life (at 2 years) additionally revealed enhanced development of hemangiosarcomas of the spleen, uterine leiomyosarcomas and pituitary adenomas, although the demonstrated predilection for these extra‐renal tumors was not as complete as with RCs. We identified the germline mutated tuberous sclerosis (Tsc2) gene as the predisposing Eker gene and revealed the tumor suppressor nature of Tsc2 gene function in renal carcinogenesis. In the present study, we examined allelic loss at the Tsc2 gene locus in uterine leiomyosarcomas and pituitary adenomas developing in hybrid F1 rats carrying the Eker mutation as well as in pituitary adenomas from non‐carrier rats. We detected loss of heterozygosity in 4 of 11 uterine leiomyosarcomas (36%) and 11 of 31 pituitary adenomas (35%) from Eker rats but in none of 9 pituitary adenomas from non‐carrier rats (P<0.05), suggesting that inactivation of the Tsc2 gene is also a critical event in the pathogenesis of these extra‐renal tumors. Our present data indicate that there might be different pathways for tumorigenesis of pituitary adenomas between Eker and non‐carrier rats.
机译:到1岁时,几乎所有Eker大鼠都发生遗传性肾癌(RCs)。对生命晚期(2岁)的Eker大鼠共发的肾外原发肿瘤的研究还显示,脾脏血管肉瘤,子宫平滑肌肉瘤和垂体腺瘤的发展增强,尽管这些肾外肿瘤的发病率并不像与RC一样完整。我们确定种系突变结节性硬化(Tsc2)基因为诱因的Eker基因,并揭示了Tsc2基因在肾脏癌变中的抑癌作用。在本研究中,我们研究了在携带Eker突变的F1杂种大鼠和非携带者的垂体腺瘤中,子宫平滑肌肉瘤和垂体腺瘤中Tsc2基因位点的等位基因缺失。我们从Eker大鼠中发现11例子宫平滑肌肉瘤中的4例(36%)和31例垂体腺瘤中的11例(35%)杂合性丧失,但在非携带者大鼠9例垂体腺瘤中均未检测到(P <0.05)。 Tsc2基因也是这些肾外肿瘤发病机制中的关键事件。我们目前的数据表明,Eker和非携带者大鼠垂体腺瘤的发生可能有不同的途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号